During the past decade, Instituto Neurologico de Colombia INDEC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto Neurologico de Colombia INDEC" are "Multiple Sclerosis, Primary Progressive" (2 trials). Many other conditions were trialed in "Instituto Neurologico de Colombia INDEC" in a lesser frequency.

Most popular intervention types in "Instituto Neurologico de Colombia INDEC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Fenebrutinib" (1 trials), "Placebo" (1 trials), "Placebo matched to fenebrutinib" (1 trials) and "Placebo matched to ocrelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Neurologico de Colombia INDEC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Neurologico de Colombia INDEC". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Instituto Neurologico de Colombia INDEC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Neurologico de Colombia INDEC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".